Arcus Capital Partners’s Humana HUM Stock Holding History

Arcus Capital Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10	Closed	-$5.18K	–	217
2022 Q4	$5.18K	Buy	+10	New	+$5.26K	﹤0.01%	295
2022 Q3	–	Sell	-1,917	Closed	-$897K	–	104
2022 Q2	$897K	Buy	1,917 +7	+0.4%	+$3.12K	0.39%	39
2022 Q1	$831K	Buy	1,910 +13	+0.7%	+$5.44K	0.3%	46
2021 Q4	$880K	Buy	1,897 +915	+93%	+$405K	0.3%	45
2021 Q3	$382K	Buy	982 +54	+6%	+$22.9K	0.14%	71
2021 Q2	$411K	Buy	928 +92	+11%	+$40.2K	0.19%	74
2021 Q1	$351K	Buy	836 +198	+31%	+$79K	0.03%	83
2020 Q4	$262K	Buy	+638	New	+$265K	0.04%	91

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arcus Capital Partners's HUM Position: Q1 2023 in Review

Arcus Capital Partners sold out of Humana (HUM) in Q1 2023, closing a stake of 10 shares — an estimated $5.18K sold.

Arcus Capital Partners first reported a position in HUM in Q4 2020 and held it in 8 quarters. The position peaked at $897K in Q2 2022. 1,045 funds tracked by Wall St. Rank hold HUM as of Q1 2023.

Arcus Capital Partners reported no remaining Humana position as of Q1 2023 after selling out during the quarter.
Arcus Capital Partners sold 10 Humana shares in Q1 2023, an estimated $5.18K.
Arcus Capital Partners first reported a position in Humana in Q4 2020 and held it in 8 quarters.
Arcus Capital Partners's Humana position peaked at $897K in Q2 2022.
1,045 funds tracked by Wall St. Rank held Humana as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.